News Center
+
-
|
Ningbo Minovar Pharmaceutical Co., Ltd. is mainly engaged in the research and development, production and sales of specialty apis and pharmaceutical intermediates. Recently, Minovartis successfully listed on the main board of the Shanghai Stock Exchange, becoming the first listed company in Ningbo that specializes in manufacturing medical specialty apis and pharmaceutical intermediates.
Today, Ningbo Minovar Pharmaceutical Co., Ltd. was successfully listed on the main board of the Shanghai Stock Exchange, becoming the first listed company specializing in the manufacture of medical specialty apis and pharmaceutical intermediates in Ningbo. The public issue of 30 million A-shares, the total share capital after the issue of 120 million shares, are tradable shares. After deducting the issuance cost, the funds raised by the issuance Institute will be used for the construction project of exporting solid preparations with an annual output of 3 billion tablets (pellets) and the construction project of drug research and development center.
Sinochem announced on February 23 that the company intends to acquire 100% of the equity of a company located in the United Kingdom through the establishment of a wholly owned subsidiary in the United Kingdom. The payment for the acquisition is expected to be £103 million.
According to the unified deployment of the Ministry of Environmental Protection, on February 15, 18 inspection teams have been stationed in 18 cities in the Beijing-Tianjin-Hebei and surrounding areas to carry out special air quality supervision in the first quarter of 2017. At present, the main problems found by the special inspection team of the Ministry of Environmental Protection include that the pressure transmission in Shijiazhuang City is not in place, and the county government is still dominated by the personnel of the environmental protection Bureau in the implementation of the heavy pollution weather emergency plan, and the participation of other departments is not high. The pollution of small and medium-sized enterprises producing pharmaceutical intermediates in Shijiazhuang city is more serious.
4 Records
Domestic Division：+86-23-68268265
International Division：+86-23-68261495
Email: sales@zyscin.com
Add: Dadi Enterprise Park, Shuitu Industrial Park, Chongqing Liangjiang New District
Copyright(C)2023,Chongqing Zyscin Pharmaceutical Technology Co., Ltd. All Rights Reserved. Supported by Toocle 31fabu Copyright Notice 渝ICP備2023007279號
